Title : Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana.

Pub. Date : 2021

PMID : 33758532






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana. efavirenz cytochrome P450 family 2 subfamily B member 6 Homo sapiens
2 Purpose: CYP2B6 liver enzyme metabolizes the two non-nucleoside reverse transcriptase inhibitors Efavirenz (EFV) and Nevirapine (NVP) used in the antiretroviral therapy (ART) regimens for HIV-infected individuals. efavirenz cytochrome P450 family 2 subfamily B member 6 Homo sapiens
3 Purpose: CYP2B6 liver enzyme metabolizes the two non-nucleoside reverse transcriptase inhibitors Efavirenz (EFV) and Nevirapine (NVP) used in the antiretroviral therapy (ART) regimens for HIV-infected individuals. efavirenz cytochrome P450 family 2 subfamily B member 6 Homo sapiens